{{Rsnum
|rsid=958546
|Gene=LRRC63
|Chromosome=13
|position=46259582
|Orientation=plus
|GMAF=0.3196
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=LRRC63
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 9.7 | 45.1 | 45.1
| HCB | 12.4 | 47.4 | 40.1
| JPT | 13.4 | 48.2 | 38.4
| YRI | 12.2 | 49.0 | 38.8
| ASW | 5.3 | 47.4 | 47.4
| CHB | 12.4 | 47.4 | 40.1
| CHD | 11.0 | 46.8 | 42.2
| GIH | 5.1 | 41.4 | 53.5
| LWK | 10.9 | 44.5 | 44.5
| MEX | 1.8 | 33.3 | 64.9
| MKK | 0.0 | 0.0 | 0.0
| TSI | 8.8 | 56.9 | 34.3
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs958546
|PubMedID=17903304
|Condition=Atrial fibrillation
|Gene=Intergenic
|Risk Allele=
|pValue=5.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs958546
|Name_s=
|Gene_s=LRRC63
|Feature=
|Evidence=PubMed ID:17903304; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes (Initial Sample Size: 1,341-1,345 individuals, depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with Atrial fibrillation.
|Drugs=
|Drug Classes=
|Diseases=Atrial Fibrillation
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356429
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs958546
|overall_frequency_n=44
|overall_frequency_d=126
|overall_frequency=0.349206
|n_genomes=29
|n_genomes_annotated=0
|n_haplomes=37
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}